Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update
? Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced ?…
0,006€
Echtzeit-Aktienkurs Alterity Therapeutics Ltd.
Bid:
Ask:
Nachrichten zur Alterity Therapeutics Ltd. Aktie
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
MELBOURNE, Australia and SAN FRANCISCO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity”…
Alterity Therapeutics’ vision for neurodegenerative care
…
Alterity Therapeutics to join Maxim Healthcare Summit By Investing.com
Alterity Therapeutics to join Maxim Healthcare Summit…
Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
MELBOURNE, Australia and SAN FRANCISCO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity”…
Alterity Therapeutics to Present at MST Financial Webinar
MELBOURNE, Australia and SAN FRANCISCO, July 24, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity”…
Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
MELBOURNE, Australia and SAN FRANCISCO, June 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity”…
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
MELBOURNE, Australia and SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity”…